Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a microbiologist at University of Pennsylvania, US. Scott Kitchen, an expert in ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

Mutations of CCR5 have been linked to improved outcome to HIV infection. Here the authors use CRISPR-Cas9 genome editing of CCR5 in mobilized hematopoietic stem progenitor cells and show ...

Determinants of HIV cell tropism & chemokine receptor usage ... exhibit a strong resistance to HIV infection and delayed progression to AIDS, respectively. A single-nucleotide polymorphism in ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...

Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective ... to treat cancer may help clear HIV from infected cells in the brain, according to a new study.

After entering host cells, it seizes control of ... our analysis revealed that while HIV-1 mRNAs are translated efficiently throughout infection, the virus suppresses the protein production ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...